Skip to main content
. 2019 Feb 20;14(2):e0212404. doi: 10.1371/journal.pone.0212404

Fig 3. Kaplan–Meier estimates of the cumulative incidence of treatment escalation according to MRE findings and endoscopic findings.

Fig 3

Probability of treatment escalation according to active disease in both ileocolonoscopy and MRE (red line, n = 9), active disease only in MRE (green line, n = 7), active disease only in ileocolonoscopy (gray line, n = 22), or remission in both ileocolonoscopy and MRE (blue line, n = 22). A low MaRIA score was associated with a longer incidence-free duration even in patients with endoscopic remission. Hazard ratio (HR) with 95% confidence interval (CI) and P value are shown. Blue line (both remission finding in SES-CD and MaRIA) represents control group).